ABSTRACT: Knowing the entire sequence of the gene encoding the DNA gyrase Subunit A (gyrA) of Edwardsiella tarda could be very useful for confirming the role of gyrA in quinolone resistance. Degenerate primers for the amplification of gyrA were designed from consensus nucleotide sequences of gyrA from 9 different Gram-negative bacteria, including Escherichia coli. With these primers, DNA segments of the predicted size were amplified from the genomic DNA of E. tarda and then the flanking sequences were determined by cassette ligation-mediated polymerase chain reaction. The nucleotide sequence of gyrA was highly homologous to those of other bacterial species, in both the whole open-reading frame and the quinolone-resistance-determining region (QRDR). The 2637-bp gyrA gene encodes a protein of 878 amino acids, preceded by a putative promoter, ribosome binding site and inverted repeated sequences for cruciform structures of DNA. However, the nucleotide sequence of the flanking region did not show any homologies with those of other bacterial DNA gyrase Subunit B genes (gyrB) and suggested the gyrase genes, gyrA and gyrB, are noncontinuous on the chromosome of E. tarda. All of the 12 quinolone-resistant isolates examined have an alteration within the QRDR, Ser 83 →Arg, suggesting that, in E. tarda, resistance to quinolones is primarily related to alterations in gyrA. Transformation with the full sequence of E. tarda gyrA bearing the Ser 83 →Arg mutation was able to complement the sequence of the gyrA temperaturesensitive mutation in the E. coli KNK453 strain and to induce increased resistance to quinolone antibiotics at 42°C.
INTRODUCTION
Most quinolone resistance in bacteria can be attributed to the genes encoding DNA gyrase or Topoisomerase IV (TOPO IV). DNA gyrase is a Type II DNA topoisomerase, and is the enzyme essential for ATPdependent, negative supercoiling of DNA, which is required for DNA replication and gene transcription (Hooper 1998) . Here, 2 A subunits and 2 B subunits, encoded by the gyrA and gyrB genes, respectively (2628 and 2415 bp in Escherichia coli, respectively), make up the tetrameric active enzyme, DNA gyrase (Bébéar et al. 2000) . TOPO IV, a C 2 E 2 tetramer encoded by the parC and parE genes, is essential for chromosome partitioning (Adams et al. 1992) . The amino acid sequences of parC and parE are homologous to some degree with those of gyrA and gyrB, respectively (Peng & Marians 1993) . The majority of the quinolone-resistance mutations in the gyrA gene are clustered in a region called the quinoloneresistance-determining region (QRDR), which includes the amino acid residues from 67 to 106 in the numbering system used in E. coli, and is supposed to be the site of interaction between the A subunit of gyrase and quinolones (Nakamura 1997 , Horii et al. 2003 . Especially, mutation at the amino acid codon Ser 83 or Asp 87 of this region has been described as the major mechanism for quinolone resistance in many different bacteria, including E. coli (Drlica & Zhao 1997 , Capilla et al. 2004 .
The gyrA genes have been cloned and sequenced from several different bacterial species, among them Escherichia coli, Neisseria gonorrhoeae, Aeromonas salmonicida, Klebsiella pneumoniae, Helicobacter pylori, Bacillus subtilis and Campylobacter jejuni (Swanberg & Wang 1987 , Dimri & Das 1990 , Oppegard & Sorum 1996 . Substitutions at positions corresponding to Ser 83 in E. coli GyrA have been detected in quinolone-resistant strains of most bacterial species. Therefore, GyrA was considered to be one of the primary targets of quinolone resistance in many bacterial species (Bébéar et al. 2000 , Goni-Urriza et al. 2002 .
Edwardsiella tarda, a Gram-negative bacterium of the Enterobacteriaceae family, causes hemorrhagic septicemia (edwardsiellosis) in fish, leading to extensive losses in both freshwater and marine aquaculture. The wide host range of E. tarda includes commercially important fishes, such as sea bream (Baxa et al. 1985) , eel (Chen & Huang 1996) , flounder (Nakatsugawa 1983) , tilapia (Kubota et al. 1981 ) and striped bass (Herman & Bullock 1986) , as well as higher vertebrates, like birds, reptiles and mammals, including humans (Janda & Abott 1993) .
Currently, Edwardsiella tarda infections in fish are treated with quinolones in many Asian countries, following the increased resistance of this bacteria to tetracyclines (Reinhardt et al. 1985 , Aoki 1988 , Stock & Wiedemann 2001 ) that have been permitted for use in humans and aquatic animals by the Food and Drug Administration (FDA). Several strains of E. tarda isolated from diseased fish have been found to show resistance to quinolones (Aoki 1988) , but nothing has been reported on the gyrA gene structure, the mutation in gyrA responsible for quinolone resistance, or other genetic bases for the decreased susceptibility to quinolones in this bacterium.
Here, we report on the cloning, sequencing and organization of the complete Edwardsiella tarda gyrA gene, as well as on the gyrA QRDRs from E. tarda isolates selected in aquatic farms for resistance to nalidixic acid.
MATERIALS AND METHODS
Bacterial cultures and drug sensitivity. A total of 138 clinical isolates of fish-pathogenic Edwardsiella tarda, isolated from 1993 to 2003 from different areas of Korea, were cultured aerobically on tryptose soy broth (TSB) (Difco) supplemented with 1% (w/v) NaCl at 25°C for 18 h. These isolates were diluted in phosphate-buffered saline (PBS) buffer (10 5 colony-forming units per 25 µl) and plated on selective tryptose soy agar (TSA) (Difco) plates containing 60 µl ml -1 nalidixic acid (NA, Sigma). From the 25 NA-resistant isolates that showed > 20 colonies on the selective media, 12 isolates were selected to give a wide distribution of years and areas of isolation in this study (see Table 3 ). These 12 NA-resistant isolates and 1 NA-sensitive isolate, E. tarda GE1 (wild type), were identified by an API 20E kit (BioMerieux) and by conventional laboratory methods, including Gram staining, growth on Salmonella-Shigella agar (SS) (Difco) plates and colony morphology. Minimum inhibitory concentrations (MIC) of quinolones (NA, oxolinic acid, norfloxacin and ciprofloxacin) were determined by the Mueller-Hinton broth (Difco) micro-doubling dilution method (Frech & Schwarz 2000) on 96-well plates with incubation at 25°C for 24 h. Escherichia coli strains and the clinical isolates of E. tarda were grown at 37°C and 25°C in TSB, respectively, and were stored in 20% glycerol at -72°C until use.
DNA extraction. All of the bacterial species were grown aerobically on TSB supplemented with 1% (w/v) NaCl at 25°C for 18 h. Cultured cells were harvested by centrifugation at 8000 × g for 10 min and lysed with 5.5% sodium dodecyl sulfate per 0.125 mg ml -1 proteinase K (Boehringer Mannheim) solution. Bacterial nucleic acids were extracted by a phenolchloroform-isoamyl alcohol (25:24:1 v/v/v) mixture. The nucleic acids were ethanol precipitated and resuspended in distilled water. The DNA was stored at -20°C until further use.
Primer design and PCR. A degenerate primer set (Table 1 ) was designed. DGYR-1 (sense primer) and DGYR-4 (anti-sense primer) were derived from the conserved nucleotide sequence of the gyrA genes in 9 bacterial species (Escherichia coli, Aeromonas salmonicida, Pectobacterium carotovorum, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pasteurella multocida, Pseudomonas aeruginosa, Serratia marcescens and Vibrio parahaemolyticus; X57174, L47978, X80798, X16817, U08817, AE006122, L29417, U56906 and AB023569, respectively). These primers were designed with the aid of gene alignment using the MACAW program (Version 2.0.5, National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD, USA). PCR amplification was carried out with a Perkin-Elmer 2400 thermal cycler (PE Applied Biosystems) in a 50 µl reaction mixture containing 100 ng of total nucleic acid isolated from 1 or 2 different bacteria, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.001% w/v gelatin, 0.5% Tween-20, 200 µM each dNTP, 1 µM each primer and 1.25 U Ampli Taq DNA polymerase (Applied Biosystems). Amplification consisted of 30 cycles at 95°C for 30 s, 50°C for 30 s and 72°C for 1 min in 0.2 ml, thin-walled tubes. The results of amplification were analyzed by 1.5% agarose gel electrophoresis. The 623 bp PCR product was purified by agarose gel electrophoresis using the Prep-A-Gene DNA Purification system (Bio-Rad Laboratories) and cloned into the TOPO-TA vector (Invitrogen) following the instructions of the manufacturer. The cloned fragment was sequenced using the Big Dye Terminator Cycle DNA Sequencing Kit (ABI PRISM, PE Applied Biosystems) and an automatic sequencer (Applied Biosystems). Nucleotide sequences were compared based upon gene alignment using the MACAW program for gyrA gene sequences of different bacterial species.
Cloning of the Edwardsiella tarda gyrA gene. A commercially available, in vitro cloning system (Takara Shuzo, Shiga, Japan) was used to amplify the previously unknown region of genomic DNA flanking the gyrA gene, based on PCR using a cassette (a double-stranded synthetic oligonucleotide with a 5'-end dephosphorylated restriction site) and cassette primers after a slight modification of the method in the manufacturer's instructions.
Preparation of the cassette-ligated bacterial DNA mixture: Edwardsiella tarda DNA (2.5 µg) was isolated and was completely digested by 30 U of the appropriate restriction enzymes. The digested bacterial nucleic acids were precipitated with cold ethanol and resuspended in 5 µl of sterile, distilled water. The nucleic acids were mixed with the ligation components (Takara Shuzo); 15 µl of Ligation Solution I, 7.5 µl of Ligation Solution II and a cassette corresponding to the restriction enzyme were used to digest the bacterial DNA. After incubation at 16°C for 30 min, the ligated nucleic acids were precipitated with cold ethanol and resuspended in 200 µl of sterile, distilled water. After heating at 94°C for 10 min, the nucleic acids were use as a template for first PCR in cassette ligationmediated PCR described below. We used EcoRI for the 5' gene extension, and then PstI and SalI sequentially for the 3' extension.
Cassette ligation-mediated PCR: Primers GYRS1R and GYRS2R for 5' end walking were derived from the sequence of 623 bp PCR products sequenced in the above experiment and corresponded to Bases 478 to 456 and Bases 399 to 374 from the 5'-end of the amplified gyrA region. Cassette Primers C1 (5'-GTA-CATATTGTCGTTAGAACGCGTAATACGACTCA-3') and C2 (5'-CGTTAGAACGCGTAAT-ACGACTCAC-TATAGGGAGA-3') (Takara Shuzo) were derived from the common nucleotide sequence of the cassettes designed for various restriction enzymes. The first PCR amplification was carried out with a Perkin-Elmer 2400 thermal cycler in a 50 µl reaction containing 34.5 µl of Edwardsiella tarda nucleic acids (EcoRI cassetteligated E. tarda DNA mixture), 1× Takara LA buffer, 2.5 U Takara LA Taq polymerase, 400 µM of each dNTP mixture, 10 pmol C1 primer and GYRS1R primer. After 10 min of heating at 94°C, amplification consisted of 30 cycles at 94°C for 30 s, 55°C for 30 s and 72°C for 4 min in 0.2 ml, thin-walled tubes. Using the same conditions, a second PCR was performed using the Primers C2 and GYRS2R and 1 µl of the product of the first PCR (Fig. 1) .
Cloning of the full-length Edwardsiella tarda gyrA gene. The full-length gyrA gene and the contiguously extended regions (3153 bp) were amplified from the chromosomal DNA of E. tarda GE1 (wild type) and RED7 (mutant type) by PCR with the primer set WGYRS/WGYRR (Table 1) . Chromosomal DNA of Escherichia coli K-12 HB101 was also used to amplify the full-length E. coli gyrA gene (2980 bp) (Swanberg & Wang 1987) in PCR with the primer set EWGS/EWGR (Table 1) . PCR amplification was carried out as described above. The resulting amplicons were cloned into the TOPO-TA vector following the instructions of the manufacturer and were introduced into E. coli TOPO by transformation. Three different plasmids, pGE1, pRED7 and pHB101 extracted from E. coli TOPO transformants by the method of Kado & Liu (1981) , were used to transform a temperature-sensitive gyrA mutant, E. coli KNK453 (Kreuzer & Cozzarelli 1979) and designated E. coli KNK453 (pGE1), E. coli KNK453 (pRED7) and E. coli KNK453 (pHB101), respectively (see Table 4 ).
RESULTS

Cloning of the Edwardsiella tarda gyrA gene
The 4505-bp nucleotide sequence of the Edwardsiella tarda gyrA gene and flanking regions has been deposited in GenBank under Accession Number DQ019315. The organization of the E. tarda gyrA gene locus is shown in Fig. 1 , with the restriction enzyme recognition sites and positions of primers used for each extension in the cassette ligation-mediated PCR shown. Sequence positions are given as negative numbers, indicating the distance upstream from the gyrA gene translation start codon, and as positive numbers, indicating the distance downstream from the gyrA gene translation termination codon.
To confirm that this ORF is the gyrA gene of Edwardsiella tarda, the nucleotide and deduced amino acid sequences were compared with those of other bacterial species and very high identities, especially to those of Gram-negative bacteria, using the BioEdit program (Version 5.0.9, Dept of Microbiology, North Carolina State University, Raleigh, NC, USA) ( Table 2 ). The higher nucleotide sequence (deduced amino acid sequence) identities between the region suspected as a QRDR in this ORF, from 199 to 318 (67 to 106), agreed with the characteristics of QRDR known to be a conserved region in gyrA of other bacteria. Additionally, this ORF exhibited relatively high identity with parC sequences of other bacteria, but less than those found in the comparison with gyrA genes ( Table 2 ). All of these results indicate that the ORF that contained the amplicon of 623 bp was the E. tarda gyrA gene.
Sequence analysis of the Edwardsiella tarda gyrA gene
The gyrA gene of Edwardsiellla tarda was larger than that of Escherichia coli, containing 3 more amino acids. In the analysis of the nucleotide sequence, we found the presence of a ribosome binding site (-16 from the ATG codon), a putative promoter region (-25 from the ATG codon) and 3 pairs of inverted repeat sequences involved in the regulation of transcription (-203/-86 and -199/-44 from the ATG codon and + 20/+ 37 from the termination codon). In addition, residues, the substitution of which confers quinolone resistance in E. (Horowitz & Wang 1987 , Swanberg & Wang 1987 , Oppegard & Sorum 1996 . However, the nucleotide sequences of the 5' and 3' end flanking regions of the E. tarda gyrA gene did not show any homologies to those of other bacterial gyrB genes and this suggests that the gyrase genes gyrB/gyrA are non-contiguous in the genome of E. tarda. We also determined the partial nucleotide sequences of another putative ORF cloned with the gyrA gene by 3' end DNA walking and found it to show 49% nucleotide sequence identity with that of the RCSC in E. coli (Fig. 1) .
Characterization of gyrA mutations in quinoloneresistant clinical isolates of Edwardsiella tarda
In order to examine the role of gyrA in quinoloneresistant Edwardsiella tarda, 12 strains were selected from 25 clinical isolates showing a MIC of > 60 µg ml -1 of NA. These quinolone-resistant E. tarda strains were also resistant to various quinolone antibiotics (Table 3) .
A 302-bp gyrA region spanning Nucleotides 106 to 407 was amplified by single-step PCR with specific primers, GYRQ/GYRQR, from quinolone-resistant Edwardsiella tarda isolates. This region encompasses the sequence equivalent to the QRDR of Escherichia coli gyrA (Residues 201 to 318) and flanking regions. The amplified sequences were ligated into the TOPO-TA vector, and the inserts were sequenced and compared. Table 3 presents the nucleotide and amino acid changes in the QRDR of the gyrA genes from clinical isolates. All 12 clinical isolates resistant to quinolone carried a single nucleotide change compared to the quinolone-susceptible E. tarda GE1. One AGC to CGC and 11 AGC to AGA alterations were found at Codon 83 in 12 quinolone-resistance E. tarda isolates, all of which would result in a Ser to Arg substitution in gyrA. Apart from this substitution, the nucleotide sequence of the QRDR in all quinolone-resistant isolates was identical to that of the susceptible strain. However, for each of the quinolone-resistant isolates, there were significant variations in the MICs of OA, NOR and CIP (Table 3) . It cannot be excluded that other mechanisms may also contribute to change the ultimate MICs of quinolone antibacterial agents in quinolone-resistant E. tarda.
Expression of Edwardsiella tarda gyrA in
Escherichia coli gyrA mutants
The PCR products which were amplified using DNA extracted from Edwardsiella tarda GE1 and RED7 isolates as templates with WGYRS/WGYRR as primers (Table 1) were cloned into the TOPO-TA vector. These plasmids contained the full-length E. tarda gyrA gene and the contiguously extended regions that have the potential to regulate the expression of the structural gyrA gene. E. coli KNK453 transformed with pGE1 (bearing the wild-type gyrA) exhibited growth on TSA plates at both the permissive temperature of 30°C and the non-permissive temperature of 42°C (Table 4) . Transformation with pRED7 (bearing a gyrA gene with Arg 83 ) increased the resistance of E. coli KNK453 to NA and OA at 42°C. The level of resistance was much lower than that of the E. tarda RED7 isolate, but significantly higher than that of E. coli KNK453 transformed with pGE1 at 42°C. The numbers in parentheses indicate the identity to parC gene 
DISCUSSION
The approach used to determine the nucleotide sequence of the Edwardsiella tarda gyrA gene is based on conservation of the QRDR and its flanking regions and thus would be applicable to sequence determination of the gyrA or parC homologues in many bacterial species (Peng & Marians 1993) .
Sequence analysis of the Edwardsiella tarda gyrA gene revealed a ribosome-binding site with homology to the Escherichia coli Shine-Dalgarno consensus sequence (GAGGG) located 16 bp upstream from the ATG translation initiation codon. At 9 bp upstream of the Shine-Dalgarno sequence, there was a region (TAATTA) that is the same as the -10 Aeromonas salmonicida promoter and similar to the -10 E. coli promoter consensus sequences (TATAAT). Further upstream, although it was not apparent, a putative -35 region (TGTATT) similar to that of Helicobacter pylori (TTGATT) (Moore et al. 1995) was observed. However, the sequences found in the -35 gyrA promoter regions in other bacteria, such as the conserved form (GTT-TACC) in E. coli (Swanberg & Wang 1987) , Klebsiella pneumoniae (Dimri & Das 1990) and Bacillus subtilis (Moriya et al. 1985) , or as other forms ATTTTCC, GTTTGCC, GTTTCCC and GTTTAAG in Serratia marcescens (Kim et al. 1998) , Pseudomonas aeruginosa (Kureishi et al. 1994) , Erwinia carotovora (Rosanas et al. 1995) and A. salmonicida (Oppegard & Sorum 1996) , respectively, were not found.
Two pairs of inverted repeat sequences that may form cruciform structures involved in the regulation of transcription were identified in the upstream region of the Edwardsiella tarda gyrA gene. These are the AAA-GAC/GTCTTT pair, located at -203/ -86 and the ACCCTC/GAGGGT pair, located at -199/-44 from the start codon, and could form a cruciform structures with unpaired loops of 111 and 149 nucleotides, respectively. The presence of these inverted repeat sequences indicated that supercoilingdependent regulation of gyrA transcription may work in E. tarda, as suggested for Escherichia coli (Horowitz & Loeb 1988) . Inverted repeat sequences have also been identified in gyrA promoters, in Aeromonas salmonicida (Oppegard & Sorum 1996) , Pseudomonas aeruginosa (Kureishi et al. 1994) and Klebsiella pneumoniae (Dimri & Das 1990) . Another inverted repeat sequence, AAGGGC/ GCCCTT, located + 20/+ 37 from the translational stop codon TAA, may act as a transcriptional termination signal by the formation of a loop structure with 11 unpaired nucleotides (Oppegard & Sorum 1996) .
In the alignment of the deduced amino acid sequence, we could not find the intragenic stretches present in the 3'-end of gyrA genes from Campylobacter jejuni, Pseudomonas aeruginosa and Helicobacter pylori (Wang et al. 1993 , Kureishi et al. 1994 , Moore et al. 1995 . The catalytic Tyr 122 involved in DNA breakage and reunion was also present, as in Escherichia coli and other bacteria (Horowitz & Wang 1987 found to be common in many Gram-negative bacteria (Dimri & Das 1990 , Kureishi et al. 1994 , Wang et al. 1993 . On the other hand, contiguous gyrB/gyrA gyrase genes have been identified in Mycoplasma pneumoniae and other Gram-positive bacteria (Colman et al. 1990 , Moriya et al. 1985 . Amino acid residues, Ser 83 and Glu 87 , of Escherichia coli gyrA have been shown to be hot spots for quinolone resistance (Vila et al. 1994 , Yolanda et al. 2003 . We examined the similarities among gyrA genes from Edwardsiella tarda isolates for quinolone resistance and found only a single substitution in all quinolone-resistant E. tarda isolates of this study: Ser 83 →Arg. The Ser 83 →Arg substitution has also been observed at a high frequency in quinolone-resistant clinical isolates of Yersinia ruckeri (Gibello et al. 2004) and as one of the mutations in quinolone-resistant clinical isolates of Enterococcus faecalis and Aeromonas salmonicida. (Korten et al. 1994 , Tankovic et al. 1996 . Additional studies of the alteration of gyrA using E. tarda mutants obtained in in vitro conditions are ongoing in our laboratory.
To examine the complementation of the Escherichia coli gyrA mutant, the full length the gyrA gene of Edwardsiella tarda was cloned and used to transform E. coli KNK453, a temperature-sensitive gyrA mutant. Transformation with the plasmid pRED7 (mutant type) was able to restore growth and induce resistance to NA and OA in E. coli KNK453 at 42°C. The level of resistance was significantly higher than that of E. coli KNK453 transformed with pGE1 (wild type) at 42°C, but did not reach the levels of the E. tarda RED7 isolate. These results indicated that: (1) the complete gyrA gene was successfully cloned, (2) the promoter region of the E. tarda gyrA gene was active in the E. coli system, (3) an E. tarda gyrA-E. coli gyrB holoenzyme complex is functionally active and (4) the variable MICs of quinolones for the quinolone-resistant E. tarda isolates might be explained by additional mechanisms, including mutations in other DNA gyrase (or TOPO IV) genes, gyrB, parC, parE, or those that can cause decreased drug permeability or increased drug efflux (Nakamura 1997) . Further study is required to determine between these possibilities. However, all quinolone-resistant isolates had a mutation within the QRDR, suggesting that the primary target for resistance is an alteration in the gyrA gene rather than in other potential genes.
Additional characterization of the Edwardsiella tarda gyrA gene reported here should facilitate further understanding of this important fish pathogenic bacteria and its quinolone resistance. However, the use of quinolones in Asian aquaculture should be avoided as much as possible, to prevent the emergence and spread of quinolone-resistant strains of E. tarda in the aquatic environment.
